HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Victor G Prieto Selected Research

Victor G Prieto Research Topics

Disease

113Neoplasms (Cancer)
03/2024 - 02/2002
111Melanoma (Melanoma, Malignant)
09/2023 - 02/2002
25Neoplasm Metastasis (Metastasis)
03/2023 - 02/2002
18Nevus (Nevi)
01/2023 - 05/2003
16Carcinoma (Carcinomatosis)
02/2024 - 01/2006
15Squamous Cell Carcinoma (Epidermoid Carcinoma)
05/2021 - 03/2006
8Sarcoma (Soft Tissue Sarcoma)
11/2023 - 04/2003
7Pigmented Nevus (Melanocytic Nevus)
11/2021 - 01/2002
7Mycosis Fungoides
11/2019 - 04/2003
6Merkel Cell Carcinoma
09/2022 - 04/2007
5Breast Neoplasms (Breast Cancer)
03/2023 - 07/2009
5Dermatitis
10/2020 - 02/2017
5Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2017 - 04/2003
5Dysplastic Nevus Syndrome (Dysplastic Nevus)
03/2007 - 11/2003
4Bullous Pemphigoid (Pemphigoid)
07/2023 - 08/2016
4Cicatrix (Scar)
12/2022 - 08/2002
4Skin Diseases (Skin Disease)
03/2022 - 12/2012
4Lymphoma (Lymphomas)
05/2021 - 02/2007
4Lymphatic Metastasis
03/2016 - 03/2002
4Actinic Keratosis
07/2014 - 06/2008
4Keratoacanthoma
07/2014 - 06/2008
4Carcinogenesis
05/2010 - 04/2006
4Renal Cell Carcinoma (Grawitz Tumor)
04/2010 - 05/2007
3Blister (Bulla)
07/2023 - 08/2016
3Disease Progression
03/2023 - 01/2009
3Basal Cell Carcinoma (Rodent Ulcer)
01/2020 - 05/2008
3Inflammation (Inflammations)
11/2019 - 01/2009
3Keratosis
09/2019 - 02/2013
3Necrosis
01/2019 - 08/2004
3Hemangiosarcoma (Angiosarcoma)
06/2018 - 01/2013
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2018 - 01/2015
3Exanthema (Rash)
12/2017 - 01/2009
3Skin Neoplasms (Skin Cancer)
04/2012 - 12/2005
2Residual Neoplasm
09/2022 - 04/2010
2Hyperphosphatemia
03/2021 - 10/2018
2Hyperpigmentation
05/2020 - 12/2015
2Acrospiroma
08/2019 - 04/2010
2Fever (Fevers)
01/2019 - 12/2016
2Panniculitis
12/2017 - 08/2015

Drug/Important Bio-Agent (IBA)

25Proteins (Proteins, Gene)FDA Link
09/2023 - 10/2002
18Biomarkers (Surrogate Marker)IBA
11/2020 - 12/2006
15ParaffinIBA
11/2019 - 10/2002
13Formaldehyde (Formol)FDA Link
11/2019 - 10/2002
11Immune Checkpoint InhibitorsIBA
07/2023 - 01/2017
10AntigensIBA
01/2023 - 05/2007
9Imatinib Mesylate (Gleevec)FDA Link
04/2010 - 08/2002
7Keratins (Keratin)IBA
06/2023 - 03/2004
7Monoclonal AntibodiesIBA
01/2023 - 02/2004
7RNA (Ribonucleic Acid)IBA
04/2021 - 08/2004
7VemurafenibIBA
03/2016 - 12/2012
6pembrolizumabIBA
03/2023 - 08/2016
6DNA (Deoxyribonucleic Acid)IBA
11/2019 - 12/2009
5NivolumabIBA
03/2023 - 08/2016
5Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
01/2022 - 04/2003
5S100 Proteins (S 100 Protein)IBA
04/2021 - 05/2003
5Messenger RNA (mRNA)IBA
01/2021 - 10/2004
5dabrafenibIBA
09/2019 - 02/2013
5AntibodiesIBA
09/2019 - 01/2006
5LigandsIBA
05/2019 - 01/2006
5MART-1 AntigenIBA
08/2017 - 07/2009
5ErbB Receptors (EGF Receptor)IBA
03/2014 - 12/2004
4CTLA-4 AntigenIBA
07/2018 - 01/2017
4Transcription Factors (Transcription Factor)IBA
03/2018 - 12/2005
4Melanins (Melanin)IBA
08/2017 - 01/2002
4Sorafenib (BAY 43-9006)FDA Link
03/2014 - 06/2008
4Platelet-Derived Growth FactorIBA
06/2011 - 04/2006
3CollagenIBA
11/2023 - 01/2002
3Telomerase (Telomerase Reverse Transcriptase)IBA
09/2023 - 01/2021
3IpilimumabIBA
01/2021 - 01/2017
3Estrogen ReceptorsIBA
01/2021 - 10/2011
3CytokinesIBA
11/2019 - 05/2012
3Anti-Bacterial Agents (Antibiotics)IBA
01/2019 - 10/2004
3MicroRNAs (MicroRNA)IBA
11/2018 - 06/2013
3Monophenol Monooxygenase (Tyrosinase)IBA
09/2017 - 06/2014
3Indicators and Reagents (Reagents)IBA
11/2016 - 01/2011
3Carcinoembryonic AntigenIBA
06/2014 - 05/2009
3Mucin-1 (CA 15-3 Antigen)IBA
06/2014 - 10/2007
3Hormones (Hormone)IBA
01/2014 - 08/2004
3Androgen Receptors (Androgen Receptor)IBA
01/2014 - 09/2005
3Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
04/2007 - 01/2003
2Myosins (Myosin)IBA
03/2024 - 05/2008
2SynaptophysinIBA
06/2023 - 04/2007
2relatlimabIBA
03/2023 - 11/2022
2Coloring Agents (Dyes)IBA
09/2022 - 02/2014
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022 - 08/2004
2Cyclin D1IBA
04/2021 - 04/2016
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
11/2020 - 02/2017
2Paclitaxel (Taxol)FDA LinkGeneric
06/2018 - 03/2016
2Brentuximab VedotinIBA
05/2018 - 12/2016
2Eosine Yellowish-(YS) (Eosin)IBA
01/2018 - 05/2009
2Hematoxylin (Haematoxylon)IBA
01/2018 - 05/2009
2VimentinIBA
08/2017 - 10/2013

Therapy/Procedure

74Therapeutics
01/2024 - 02/2002
10Drug Therapy (Chemotherapy)
09/2022 - 10/2004
9Aftercare (After-Treatment)
01/2021 - 08/2002
8Immunotherapy
03/2023 - 08/2016
8Radiotherapy
01/2016 - 03/2002
7Lymph Node Excision (Lymph Node Dissection)
12/2019 - 07/2002
3Neoadjuvant Therapy
03/2023 - 07/2018
2Debridement
01/2019 - 10/2004